FDA Inspection 1039861 — CSL Plasma, Inc.
The FDA completed an inspection of CSL Plasma, Inc. on December 7, 2017 in Southfield, MI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2017
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Southfield, MI (United States)